Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to make cancer cells stop dividing so they stop growing or die. Combining chemotherapy with corticosteroids may be an effective treatment for prostate cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of methylprednisolone with or without doxorubicin in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Timeline

Start

1998-10

Primary completion

2001-03

Completion

2001-03

Outcome

Outcome not reported

Stopped: “lack of inclusions”

Drugs

Indications